NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
-4.07%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$996M
AUM Growth
+$996M
(-2.4%)
Cap. Flow
+$58.7M
Cap. Flow
% of AUM
5.9%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
137
New
19
Increased
25
Reduced
38
Closed
13
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$27.4M |
| 2 |
Establishment Labs
ESTA
|
$24.9M |
| 3 |
Peloton Interactive
PTON
|
$15.6M |
| 4 |
Savara
SVRA
|
$13.9M |
| 5 |
The Bancorp
TBBK
|
$12.8M |
Top Sells
| 1 |
Pathward Financial
CASH
|
$27.2M |
| 2 |
Lyra Therapeutics
LYRA
|
$17.5M |
| 3 |
Red Violet
RDVT
|
$16.9M |
| 4 |
Dyne Therapeutics
DYN
|
$12.4M |
| 5 |
Golden Entertainment
GDEN
|
$9.92M |
Sector Composition
| 1 | Healthcare | 68.09% |
| 2 | Consumer Discretionary | 12.03% |
| 3 | Financials | 6.24% |
| 4 | Communication Services | 6.07% |
| 5 | Technology | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Codexis
CDXS
$246M
| $11.3M | 0.66% | 3,629,622 -832,256 | -19% | -$2.58M |
|
|
EGRX
27
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $11M | 0.64% | 1,962,070 +703,308 | +56% | +$3.94M |
|
28
Aura Biosciences
AURA
$389M
| $9.6M | 0.56% | 1,270,035 -51,825 | -4% | -$392K |
|
29
Viemed Healthcare
VMD
$286M
| $9.4M | 0.55% | 1,435,122 -115,000 | -7% | -$753K |
|
30
Syndax Pharmaceuticals
SNDX
$1.41B
| $9.3M | 0.54% | 453,232 -12,027 | -3% | -$247K |
|
31
Immatics
IMTX
$619M
| $9.16M | 0.54% | 787,974 | – | – |
|
32
Tourmaline Bio
TRML
$601M
| $9.01M | 0.53% | 700,907 | – | – |
|
33
Vanda Pharmaceuticals
VNDA
$279M
| $9M | 0.53% | 1,593,516 +580,265 | +57% | +$3.28M |
|
34
Elutia
ELUT
$96.7M
| $8.91M | 0.52% | 1,795,697 +145,697 | +9% | +$723K |
|
35
eHealth
EHTH
$118M
| $8.66M | 0.51% | 1,911,821 | – | – |
|
36
Eventbrite
EB
$256M
| $7.74M | 0.45% | +1,600,000 | New | +$7.74M |
|
37
Luxfer Holdings
LXFR
$359M
| $7M | 0.41% | 604,143 -81,110 | -12% | -$940K |
|
|
ILPT
38
Industrial Logistics Properties Trust
ILPT
$409M
| $6.88M | 0.4% | 1,869,953 -11,179 | -0.6% | -$41.1K |
|
39
Ocular Therapeutix
OCUL
$2.12B
| $6.84M | 0.4% | +1,000,000 | New | +$6.84M |
|
40
Noodles & Co
NDLS
$33.1M
| $6.81M | 0.4% | 4,308,329 +275,000 | +7% | +$435K |
|
41
The RMR Group
RMR
$285M
| $6.8M | 0.4% | 300,792 -45,000 | -13% | -$1.02M |
|
42
Disc Medicine
IRON
$2.07B
| $6.76M | 0.4% | +150,000 | New | +$6.76M |
|
43
Alta Equipment Group
ALTG
$267M
| $6.74M | 0.39% | 838,222 +435,713 | +108% | +$3.5M |
|
44
Cogent Biosciences
COGT
$1.69B
| $6.67M | 0.39% | 790,936 | – | – |
|
45
Mineralys Therapeutics
MLYS
$1.03B
| $6.23M | 0.36% | 532,506 +200,000 | +60% | +$2.34M |
|
46
Astria Therapeutics
ATXS
$349M
| $6.14M | 0.36% | +675,000 | New | +$6.14M |
|
47
Benitec Biopharma
BNTC
$348M
| $5.88M | 0.34% | +841,395 | New | +$5.88M |
|
48
VistaGen Therapeutics
VTGN
$102M
| $5.28M | 0.31% | 1,517,696 | – | – |
|
49
The ONE Group
STKS
$86.4M
| $5.11M | 0.3% | 1,202,528 +654,818 | +120% | +$2.78M |
|
50
Nektar Therapeutics
NKTR
$568M
| $5.1M | 0.3% | 4,110,000 +1,634,046 | +66% | +$2.03M |
|